Laserscope Shareholders Settle Insider Trading Claims
Two shareholders of medical device company Laserscope accused by the U.S. Securities and Exchange Commission of trading on insider information in advance of a merger announcement have agreed to pay $250,000...To view the full article, register now.
Already a subscriber? Click here to view full article